Skip to main content
. 2023 Jul 17;20(1):91–102. doi: 10.1002/alz.13386

TABLE 2.

Baseline prediction of dementia phenoconversion in iRBD.

Percent abnormal a
Test HR (95% CI) Parkinsonism‐first Dementia‐first p‐Value
Attention domain (any test) 4.65 (2.49, 8.7) 26.5 64.1 <0.001
TMT A 3.82 (1.91, 7.64) 15.2 42.1 0.003
Stroop interference 5.62 (2.29, 13.82) 6.1 35.0 0.003
Digit span backward 5.14 (1.38, 19.17) 0.0 9.4 0.073
Digit span forward 1.93 (0.97, 3.85) 12.1 22.6 0.245
Executive domain (any test) 6.05 (2.97, 12.33) 36.2 73.1 <0.001
TMT B 4.62 (2.32, 9.21) 33.3 64.8 0.003
TMT B‐A 7.86 (3.19, 19.41) 17.9 59.4 0.003
Phonemic fluency 2.35 (1.06, 5.19) 9.4 19.0 0.189
Semantic fluency 4.14 (2.19, 7.84) 8.6 28.6 0.004
Memory domain (any test) 3.26 (1.81, 5.86) 16.4 53.3 <0.001
Word list immediate recall 4.06 (2.01, 8.16) 11.0 35.0 0.003
Word list delayed recall 2.18 (1.08, 4.39) 11.3 36.8 0.003
Word list recognition 1.88 (0.84, 4.19) 4.5 20.5 0.073
Visuospatial domain
Figure copy 2.07 (1.06, 4.03) 14.3 31.5 0.064
Language Domain
Naming 6.17 (1.83, 20.79) 6.9 17.4 0.460
MCI 2.74 (1.42, 5.3) 30.2 58.0 0.001

Note: Hazard ratios with 95% confidence intervals are presented according to competing risks regression analysis adjusting for age, sex, education, depression, and study center. Hazard ratios for which the confidence intervals do not cross one (i.e., p < 0.05) are highlighted in bold. Values for the Visuospatial and Language domains are not shown since only one test was available for each domain.

Abbreviations: iRBD, isolated/idiopathic rapid eye movement sleep behavior disorder; MCI, mild cognitive impairment; TMT, Trail Making Test.

a

Impaired testing based on a z‐score cutoff of −1.5.